Neuroprotection in Acute Cerebral Ischemia II

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 364 participants.

Also called NCT07552818

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 364 participants (planned count) (from the registry)
Sponsor
IGEA (from the registry)
Registry
  • NCT NCT07552818
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07552818. Randomized; quadruple masking; primary purpose treatment. Start 2026-06-15 (anticipated); primary completion 2029-06-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Neuroprotection in Acute Cerebral Ischemia II
Condition
Acute Ischemic Stroke
Intervention (Device)
Treatment with the I-NIC medical device for neuroprotection
Intervention (Device)
Treatment with I-NIC sham device
Lead sponsor
IGEA (class: industry)

Record details

Record id
cardio:ct-nct07552818
Content hash
cd6ebfd2510948011a1c43fd422c17a9d17ffd95417c2992919b070fdf13014a